SAMBA HIV Semiquantitative Test, a New Point-of-Care Viral-Load-Monitoring Assay for Resource-Limited Settings
Open Access
- 1 September 2014
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 52 (9) , 3377-3383
Abstract
Routine viral-load (VL) testing of HIV-infected individuals on antiretroviral therapy (ART) is used to monitor treatment efficacy. However, due to logistical challenges, implementation of VL has been difficult in resource-limited settings. The aim of this study was to evaluate the performance of the SAMBA semi-Q (simple amplification-based assay semiquantitative test for HIV-1) in London, Malawi, and Uganda. The SAMBA semi-Q can distinguish between patients with VLs above and below 1,000 copies/ml. The SAMBA semi-Q was validated with diluted clinical samples and blinded plasma samples collected from HIV-1-positive individuals. SAMBA semi-Q results were compared with results from the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test, v2.0. Testing of 96 2- to 10-fold dilutions of four samples containing HIV-1 subtype C as well as 488 samples from patients in the United Kingdom, Malawi, and Uganda yielded an overall accuracy for the SAMBA semi-Q of 99% (95% confidence interval [CI], 93.8 to 99.9%) and 96.9% (95% CI 94.9 to 98.3%), respectively, compared to to the Roche test. Analysis of VL data from patients in Malawi and Uganda showed that the SAMBA cutoff of 1,000 copies/ml appropriately distinguished treated from untreated individuals. Furthermore, analysis of the viral loads of 232 patients on ART in Malawi and Uganda revealed similar patterns for virological control, defined as either Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach , 2010). This study suggests that the SAMBA semi-Q has adequate concurrency with the gold standard measurements for viral load. This test can allow VL monitoring of patients on ART at the point of care in resource-limited settings.Keywords
This publication has 17 references indexed in Scilit:
- Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Immunologic Criteria Are Poor Predictors of Virologic Outcome: Implications for HIV Treatment Monitoring in Resource-Limited SettingsClinical Infectious Diseases, 2011
- Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern UgandaBMC Infectious Diseases, 2009
- Monitoring of antiretroviral therapy in low-resource settingsThe Lancet, 2008
- HIV-1 Viral Load Assays for Resource-Limited SettingsPLOS Medicine, 2006
- Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessmentThe Lancet, 2006
- HIV-1 viral load blips are of limited clinical significanceJournal of Antimicrobial Chemotherapy, 2006
- Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAARTJAMA, 2005
- Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.2004
- Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment.JAMA, 2002